Showing 1 - 12 results of 12 for search 'Kapil N. Bhalla', query time: 0.07s
Refine Results
-
1
Advances in myelofibrosis: a clinical case approach by John O. Mascarenhas, Attilio Orazi, Kapil N. Bhalla, Richard E. Champlin, Claire Harrison, Ronald Hoffman
Published 2013-10-01
Article -
2
-
3
Automated reporter quantification in vivo: high-throughput screening method for reporter-based assays in zebrafish. by Steven L Walker, Junko Ariga, Jonathan R Mathias, Veena Coothankandaswamy, Xiayang Xie, Martin Distel, Reinhard W Köster, Michael J Parsons, Kapil N Bhalla, Meera T Saxena, Jeff S Mumm
Published 2012-01-01
Article -
4
Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells by Warren Fiskus, Taghi Manshouri, Christine Birdwell, Christopher P. Mill, Lucia Masarova, Prithviraj Bose, Tapan M. Kadia, Naval Daver, Courtney D. DiNardo, Gautam Borthakur, Joseph D. Khoury, Srdan Verstovsek, Kapil N. Bhalla
Published 2022-01-01
Article -
5
Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM) by Christopher P. Mill, Warren C. Fiskus, Courtney D. DiNardo, Patrick Reville, John A. Davis, Christine E. Birdwell, Kaberi Das, Hanxi Hou, Koichi Takahashi, Lauren Flores, Xinjia Ruan, Xiaoping Su, Sanam Loghavi, Joseph D. Khoury, Kapil N. Bhalla
Published 2024-02-01
Article -
6
Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia by Jorge Cortes, Moshe Talpaz, Hedy P. Smith, David S. Snyder, Jean Khoury, Kapil N. Bhalla, Javier Pinilla-Ibarz, Richard Larson, David Mitchell, Scott C. Wise, Thomas J. Rutkoski, Bryan D. Smith, Daniel L. Flynn, Hagop M. Kantarjian, Oliver Rosen, Richard A. Van Etten
Published 2017-03-01
Article -
7
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c) by Warren Fiskus, Steffen Boettcher, Naval Daver, Christopher P. Mill, Koji Sasaki, Christine E. Birdwell, John A. Davis, Koichi Takahashi, Tapan M. Kadia, Courtney D. DiNardo, Qi Jin, Yuan Qi, Xiaoping Su, Gerard M. McGeehan, Joseph D. Khoury, Benjamin L. Ebert, Kapil N. Bhalla
Published 2022-01-01
Article -
8
Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis by Prajwal Boddu, Hagop M. Kantarjian, Guillermo Garcia-Manero, Farhad Ravandi, Srdan Verstovsek, Elias Jabbour, Gautam Borthakur, Marina Konopleva, Kapil N. Bhalla, Naval Daver, Courtney D. DiNardo, Christopher B. Benton, Koichi Takahashi, Zeev Estrov, Sherry R. Pierce, Michael Andreeff, Jorge E. Cortes, Tapan M. Kadia
Published 2017-07-01
Article -
9
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1 by Warren Fiskus, Christopher P. Mill, Christine Birdwell, John A. Davis, Kaberi Das, Steffen Boettcher, Tapan M. Kadia, Courtney D. DiNardo, Koichi Takahashi, Sanam Loghavi, Michael J. Soth, Tim Heffernan, Gerard M. McGeehan, Xinjia Ruan, Xiaoping Su, Christopher R. Vakoc, Naval Daver, Kapil N. Bhalla
Published 2023-04-01
Article -
10
Genome-wide DNA methylation maps in follicular lymphoma cells determined by methylation-enriched bisulfite sequencing. by Jeong-Hyeon Choi, Yajun Li, Juyuan Guo, Lirong Pei, Tibor A Rauch, Robin S Kramer, Simone L Macmil, Graham B Wiley, Lynda B Bennett, Jennifer L Schnabel, Kristen H Taylor, Sun Kim, Dong Xu, Arun Sreekumar, Gerd P Pfeifer, Bruce A Roe, Charles W Caldwell, Kapil N Bhalla, Huidong Shi
Published 2010-09-01
Article -
11
Correction: Genome-Wide DNA Methylation Maps in Follicular Lymphoma Cells Determined by Methylation-Enriched Bisulfite Sequencing. by Jeong-Hyeon Choi, Yajun Li, Juyuan Guo, Lirong Pei, Tibor A. Rauch, Robin S. Kramer, Simone L. Macmil, Graham B. Wiley, Lynda B. Bennett, Jennifer L. Schnabel, Kristen H. Taylor, Sun Kim, Dong Xu, Arun Sreekumar, Gerd P. Pfeifer, Bruce A. Roe, Charles W. Caldwell, Kapil N. Bhalla, Huidong Shi
Published 2011-01-01
Article -
12
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia by Feng Wang, Kiyomi Morita, Courtney D. DiNardo, Ken Furudate, Tomoyuki Tanaka, Yuanqing Yan, Keyur P. Patel, Kyle J. MacBeth, Bin Wu, Guowen Liu, Mark Frattini, Jairo A. Matthews, Latasha D. Little, Curtis Gumbs, Xingzhi Song, Jianhua Zhang, Erika J. Thompson, Tapan M. Kadia, Guillermo Garcia-Manero, Elias Jabbour, Farhad Ravandi, Kapil N. Bhalla, Marina Konopleva, Hagop M. Kantarjian, P. Andrew Futreal, Koichi Takahashi
Published 2021-05-01
Article